Celladon Corporation Company Profile
Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in developing molecular therapies for the treatment of heart failure. The companyâs products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in heart muscle cells. Celladonâs first product candidate, MYDICAR®, delivers the gene for the SERCA2a enzyme and is currently being tested in Phase 1 and 2 clinical trials. Celladon is also developing traditional small molecule activators of SERCA2a for the treatment of heart failure. To learn more about Celladon, visit Celladonâs website at www.celladon.net.
Location
2223 Avenida de la Playa #206
La Jolla
California
92037
United States of America
Contact
Phone: 858.366.4288
Fax: 858.964.0974
Email: info@celladon.net
News Articles
Lonza, Celladon sign Mydicar GMP manufacturing agreement
Lonza and Celladon have signed a process transfer and GMP manufacturing agreement for Mydicar, a genetically targeted enzyme replacement therapy.
Lonza to manufacture heart failure therapy for Celladon Corporation
Contract manufacturing company Lonza and Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, have entered i...
SAN DIEGO , May 8, 2013 /- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that i...
Celladon Corporation Selected as Winner of Red Herring's "Top 100 North America Tech Startup"
SAN DIEGO , May 29, 2013 /- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases announced today it had been...
Celladon Corporation Announces First Patient Dosed in CUPID Phase 2b Trial of MYDICAR for ...
Celladon Corporation Announces First European Patient Dosed in CUPID Phase 2b Trial of MYDICAR ...
Celladon Corporation Receives Patent from United States Patent and Trademark Office
SAN DIEGO, July 19, 2012 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced...
Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced toda...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Celladon Corp., based in La Jolla, Calif., was launched in October 2004 as a privately held biotechnology company with the goal of becoming the leader in developing molecular therapies for the treatme...
Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in develop...
More Information about "Celladon Corporation" on BioPortfolio
We have published hundreds of Celladon Corporation news stories on BioPortfolio along with dozens of Celladon Corporation Clinical Trials and PubMed Articles about Celladon Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celladon Corporation Companies in our database. You can also find out about relevant Celladon Corporation Drugs and Medications on this site too.
